Will DigitalOcean Stock Bounce Back?
DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…
Sell
42
LABD Quote, Financials, Valuation and Earnings
Last price:
$8.69
Seasonality move
:
-19.77%
Day range:
$8.63 - $9.06
52-week range:
$4.78 - $16.05
Dividend yield:
3.77%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
7.9M
Avg. volume:
10.2M
1-year change:
2.96%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- |
|
FAZ
Direxion Daily Financial Bear 3x Shares
|
-- | -- | -- | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
$8.70 | -- | -- | -- | $0.05 | 3.77% | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
$27.46 | -- | -- | -- | $0.28 | 4.57% | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
$6.32 | -- | -- | -- | $0.10 | 5.8% | -- |
|
FAZ
Direxion Daily Financial Bear 3x Shares
|
$5.09 | -- | -- | -- | $0.10 | 7.69% | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
$13.63 | -- | -- | -- | $0.23 | 6.93% | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
$37.46 | -- | -- | -- | $0.47 | 6.3% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -5.317 | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -3.831 | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -0.841 | -- | -- |
|
FAZ
Direxion Daily Financial Bear 3x Shares
|
-- | -3.308 | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -4.762 | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -3.725 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- | -- |
|
FAZ
Direxion Daily Financial Bear 3x Shares
|
-- | -- | -- | -- | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bear 3X Shares vs. Competitors
-
Which has Higher Returns LABD or DRV?
Direxion Daily Real Estate Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Real Estate Bear 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- -
What do Analysts Say About LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Real Estate Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Real Estate Bear 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 DRVDirexion Daily Real Estate Bear 3X Shares0 0 0 -
Is LABD or DRV More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Real Estate Bear 3X Shares has a beta of -3.246, suggesting its less volatile than the S&P 500 by 424.55%.
-
Which is a Better Dividend Stock LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.77%. Direxion Daily Real Estate Bear 3X Shares offers a yield of 4.57% to investors and pays a quarterly dividend of $0.28 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Real Estate Bear 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Real Estate Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Real Estate Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Real Estate Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- --
-
Which has Higher Returns LABD or EDZ?
Direxion Daily MSCI Emerging Markets Bear 3x Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily MSCI Emerging Markets Bear 3x Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- -
What do Analysts Say About LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Emerging Markets Bear 3x Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily MSCI Emerging Markets Bear 3x Shs, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily MSCI Emerging Markets Bear 3x Shs.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs0 0 0 -
Is LABD or EDZ More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily MSCI Emerging Markets Bear 3x Shs has a beta of -2.360, suggesting its less volatile than the S&P 500 by 335.996%.
-
Which is a Better Dividend Stock LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.77%. Direxion Daily MSCI Emerging Markets Bear 3x Shs offers a yield of 5.8% to investors and pays a quarterly dividend of $0.10 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily MSCI Emerging Markets Bear 3x Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily MSCI Emerging Markets Bear 3x Shs quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily MSCI Emerging Markets Bear 3x Shs's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily MSCI Emerging Markets Bear 3x Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily MSCI Emerging Markets Bear 3x Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- --
-
Which has Higher Returns LABD or FAZ?
Direxion Daily Financial Bear 3x Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Financial Bear 3x Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- FAZDirexion Daily Financial Bear 3x Shares-- -- -- -
What do Analysts Say About LABD or FAZ?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Financial Bear 3x Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Financial Bear 3x Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Financial Bear 3x Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 FAZDirexion Daily Financial Bear 3x Shares0 0 0 -
Is LABD or FAZ More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Financial Bear 3x Shares has a beta of -3.053, suggesting its less volatile than the S&P 500 by 405.282%.
-
Which is a Better Dividend Stock LABD or FAZ?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.77%. Direxion Daily Financial Bear 3x Shares offers a yield of 7.69% to investors and pays a quarterly dividend of $0.10 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Financial Bear 3x Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or FAZ?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Financial Bear 3x Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Financial Bear 3x Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Financial Bear 3x Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Financial Bear 3x Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- FAZDirexion Daily Financial Bear 3x Shares-- -- -- --
-
Which has Higher Returns LABD or HIBS?
Direxion Daily S&P 500 High Beta Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily S&P 500 High Beta Bear 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares-- -- -- -
What do Analysts Say About LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P 500 High Beta Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily S&P 500 High Beta Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily S&P 500 High Beta Bear 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares0 0 0 -
Is LABD or HIBS More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily S&P 500 High Beta Bear 3X Shares has a beta of -4.316, suggesting its less volatile than the S&P 500 by 531.574%.
-
Which is a Better Dividend Stock LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.77%. Direxion Daily S&P 500 High Beta Bear 3X Shares offers a yield of 6.93% to investors and pays a quarterly dividend of $0.23 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily S&P 500 High Beta Bear 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily S&P 500 High Beta Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily S&P 500 High Beta Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily S&P 500 High Beta Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily S&P 500 High Beta Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares-- -- -- --
-
Which has Higher Returns LABD or TECS?
Direxion Daily Technology Bear 3x Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Technology Bear 3x Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- TECSDirexion Daily Technology Bear 3x Shares-- -- -- -
What do Analysts Say About LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Technology Bear 3x Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Technology Bear 3x Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Technology Bear 3x Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 TECSDirexion Daily Technology Bear 3x Shares0 0 0 -
Is LABD or TECS More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.907, which suggesting that the stock is 390.675% less volatile than S&P 500. In comparison Direxion Daily Technology Bear 3x Shares has a beta of -3.498, suggesting its less volatile than the S&P 500 by 449.775%.
-
Which is a Better Dividend Stock LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.05 per share corresponding to a yield of 3.77%. Direxion Daily Technology Bear 3x Shares offers a yield of 6.3% to investors and pays a quarterly dividend of $0.47 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Technology Bear 3x Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Technology Bear 3x Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Technology Bear 3x Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Technology Bear 3x Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Technology Bear 3x Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- TECSDirexion Daily Technology Bear 3x Shares-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Cognizant Stock Be In 5 Years?
Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…
NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
33
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
60
MRUS alert for May 24
Merus NV [MRUS] is up 32.55% over the past day.
Buy
57
RGC alert for May 24
Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.
Buy
90
OKLO alert for May 24
Oklo [OKLO] is up 23.11% over the past day.
